A novel 1297-1304delGCCTGCCA mutation in the exon 10 of the thyroid hormone receptor β gene causes resistance to thyroid hormone
- PMID: 23315966
- DOI: 10.1007/BF03260060
A novel 1297-1304delGCCTGCCA mutation in the exon 10 of the thyroid hormone receptor β gene causes resistance to thyroid hormone
Abstract
Introduction: Resistance to the thyroid hormone (RTH) is an inherited syndrome of reduced tissue responsiveness to hormonal action caused by mutations located in the ligand-binding domain and adjacent hinge region of the thyroid hormone receptor β (TRβ) gene.
Patient: The patient in this study, a 42-year-old Caucasian male, came to medical attention because he experienced atrial fibrillation. Clinical evaluation showed a small and diffuse goiter and biochemical tests revealed markedly elevated concentrations of total T(4), total T(3), and free T(4), normal thyroid-stimulating hormone (TSH) values and slightly increased I(131) thyroid uptake at 24 hours. The thyroperoxidase, thyroglobulin, and TSH receptor antibodies were positive. He was treated with cabergoline plus methimazole. This treatment was stopped because of the inconsistent response, monotherapy with tri-iodothyroacetic acid (TRIAC) was then prescribed after molecular diagnosis confirmed RTH syndrome.
Methods: The exons 9 and 10 of the TRβ gene, including splicing signals and the flanking intronic regions of each intron, were amplified with PCR. DNA sequences from each amplified fragment were performed with the Taq polymerase-based chain terminator method and using the specific TRβ forward and reverse primers.
Results: Direct sequence analysis of the exons 9 and 10 of the TRβ gene revealed an eight basepair deletion, 1297-1304delGCCTGCCA in exon 10. The mutation produces a frameshift at amino acid 433 and introduces a stop codon TGA at position 461, 85 nucleotides downstream from deletion. This alteration was not detected in either the father or mother of the patient, suggesting a de novo mutation that was confirmed by DNA fingerprint analysis.
Conclusions: In the present study we have identified a novel sporadic mutation corresponding to 1297-1304delGCCTGCCA deletion in the activating function 2 (AF-2) region of TRβ. To our knowledge, this is the first time that the presence of a partial deletion of eight nucleotides in the TRβ has been reported.
Similar articles
-
A novel 1297-1304delGCCTGCCA mutation in the exon 10 of the thyroid hormone receptor beta gene causes resistance to thyroid hormone.Mol Diagn. 2004;8(3):163-9. Mol Diagn. 2004. PMID: 15771554
-
A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome.Exp Clin Endocrinol Diabetes. 2006 Nov;114(10):569-76. doi: 10.1055/s-2006-956169. Exp Clin Endocrinol Diabetes. 2006. PMID: 17177139
-
Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.J Clin Endocrinol Metab. 1999 Nov;84(11):3919-28. doi: 10.1210/jcem.84.11.6080. J Clin Endocrinol Metab. 1999. PMID: 10566629
-
Is there a role for inherited TRβ mutation in human carcinogenesis? [corrected].Arq Bras Endocrinol Metabol. 2012 Feb;56(1):67-71. doi: 10.1590/s0004-27302012000100010. Arq Bras Endocrinol Metabol. 2012. PMID: 22460197 Review.
-
Syndrome of resistance to thyroid hormone: insights into thyroid hormone action.Proc Soc Exp Biol Med. 1996 Jan;211(1):49-61. doi: 10.3181/00379727-211-43951. Proc Soc Exp Biol Med. 1996. PMID: 8594618 Review.
Cited by
-
Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions.Stem Cells Int. 2019 Apr 30;2019:5496891. doi: 10.1155/2019/5496891. eCollection 2019. Stem Cells Int. 2019. PMID: 31182964 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources